Publication|Articles|April 3, 2024
- Pharmaceutical Commerce - April 2024
- Volume 19
- Issue 2
Pharmaceutical Commerce - April 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce April 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Cold Chain, PBMs, and Morealmost 2 years ago
Looking Ahead to LogiPharma Europealmost 2 years ago
An 'Access' Double-Take: Fresh Views on PAPs and Patient Hubsalmost 2 years ago
The Pharma Cold Chain: More Visible, More Sustainable—and Colderalmost 2 years ago
The Power of Patient Adherence Tools to Improve the Patient Journeyalmost 2 years ago
Tackling Patient-Related Challenges Along the Pharma Supply Chainalmost 2 years ago
Fail-First Policies Are Harming Patientsalmost 2 years ago
In Search of the ‘Bad Guy’almost 2 years ago
What Will Change in the Pharma Industry Look Like?almost 2 years ago
Who Moved My Prescription? Part IIINewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis to Build Fourth US Radioligand Therapy Facility to Strengthen Supply Chain
2
Amazon Pharmacy Adds FDA-Approved Wegovy Pill, the First Oral GLP-1 for Weight Loss
3
Pharma Pulse: Amazon Pharmacy Sells Oral Wegovy, J&J’s Billion-Dollar Hub, and the Debt-Housing Crisis
4
Managing Tariff-Driven Cost Increases Without Disrupting Customers
5

